Crown Prince Mohammed bin Salman continues to exercise de facto authority as Saudi Arabia’s prime minister and designated heir, overseeing the third and final phase of Vision 2030 from 2026 to 2030 while directing cabinet sessions and the Public Investment Fund’s economic diversification strategy. Recent diplomatic activity, including direct communications with Chinese President Xi Jinping and coordination with the United States on regional issues, has reinforced his central role in foreign policy. King Salman’s brief medical tests in May 2026 produced no reported adjustments to royal succession procedures through the Allegiance Council, where MBS retains a clear institutional path with no evident internal challenges or health-related disruptions. These developments have shaped trader assessments toward sustained leadership continuity, though the market remains sensitive to any future shifts in royal health, cabinet dynamics, or major geopolitical escalations within the resolution window.